Liver transplantation for sinusoidal obstructive syndrome (veno-occlusive disease): Case report with review of the literature and the UNOS database

Clinical Transplantation

Volumn 22, Issue 4, 2008, Pages 397-404

  Membreno, Fernando E ^a   Ortiz, Jorge ^a   Foster, Preston F ^a   Wright, Francis ^a   Ostrower, Victor S ^a   Metter, John D ^a   Palma Vargas, Juan ^a   Lemaistre, Charles F ^a  

^a TEXAS TRANSPLANT INSTITUTE   (United States)

Author keywords

Liver transplantation; Marrow; Obstructive; Sinusoidal; Veno occlusive

Indexed keywords

ALLOPURINOL; BUSULFAN; CYCLOPHOSPHAMIDE; DEFIBROTIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; METHOTREXATE; PREDNISONE; TACROLIMUS; VALGANCICLOVIR;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ASCITES; BILE LEAKAGE; BONE MARROW BIOPSY; BRAIN DISEASE; CANCER RECURRENCE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOMEGALOVIRUS INFECTION; DETERIORATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HEMATOMA; HEPATIC ARTERY; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; KIDNEY FAILURE; LEUKAPHERESIS; LEUKOPENIA; LIVER ABSCESS; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SINUSOIDAL OBSTRUCTIVE SYNDROME; SPLENOMEGALY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; WEIGHT GAIN;

ADULT; DATABASES, FACTUAL; FATAL OUTCOME; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LIVER TRANSPLANTATION; MALE; STEM CELL TRANSPLANTATION;

EID: 48249115599     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00814.x     Document Type: Review

References (44)

1. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 1984: 4: 116.
2. Jones RJ, Lee KS, Beschorner WE et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987: 44: 778.
3. Ganem G, Saint-Marc Girardin MF, Kuentz M et al. Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988: 14: 879.
4. Carreras E, Bertz H, Arcese W et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998: 92: 3599.
5. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 1993: 118: 255.
6. De Leve LD, Wang X. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology 2000: 60: 143.
7. Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB. Venoocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993: 11: 1729.
8. Nimer SD, Milewicz AL, Champlin RE, Busuttil RW. Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 1990: 49: 819.
9. Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, DiPersio JF. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant. Bone Marrow Transplant 1991: 8: 421.
10. Schlitt HJ, Tischler HJ, Ringe B. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation - clinical and immunological considerations. Bone Marrow Transplant 1995: 16: 473.
11. Dowlati A, Honore P, Damas P et al. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation 1995: 60: 106.
12. Hagglund H, Ringden O, Ericzon BG et al. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation. Transplantation 1996: 62: 1076.
13. Bunin N, Leahey A, Dunn S. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation. Transplantation 1996: 61: 664.
14. Rosen HR, Martin P, Schiller GJ et al. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transpl Surg 1996: 2: 225.
15. Salat C, Holler E, Wolf C et al. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation. Bone Marrow Transplant 1997: 19: 487.
16. Norris S, Crosbie O, McEntee G et al. Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation. Transplantation 1997: 63: 1521.
17. Kim ID, Egawa H, Marui Y et al. A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation. Am J Transplant 2002: 2: 796.
18. MacQuillan GC, Mutimer D. Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: A depressing experience. QJM 2004: 97: 581.
19. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines. Ann Intern Med 1996: 125: 625.
20. Zager RA, O'Quigley J, Zager BK et al. Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients. Am J Kidney Dis 1989: 13: 210.
21. De Leve LD. Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation. Hepatology 1996: 24: 830.
22. Honjo I, Suou T, Hirayama C. Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. Res Commun Chem Pathol Pharmacol 1988: 61: 149.
23. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995: 85: 3005.
24. Vivarelli M, Cucchetti A, La Barba G et al. Ischemic arterial complications after liver transplantation in the adult: Multivariate analysis of risk factors. Arch Surg 2004: 139: 1069.
25. De Leve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002: 22: 27.
26. Attal M, Huguet F, Rubie H et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial. Blood 1992: 79: 2834.
27. Bearman SI, Hinds MS, Wolford JL et al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant 1990: 5: 407.
28. Marsa-Vila L, Gorin NC, Laporte JP et al. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation. Eur J Haematol 1991: 47: 346.
29. Gluckman E, Jolivet I, Scrobohaci ML et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 1990: 74: 277.
30. Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB. A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation. Br J Haematol 1993: 84: 724.
31. Terra SG, Spitzer TR, Tsunoda SM. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation. Pharmacotherapy 1997: 17: 929.
32. Ringden O, Remberger M, Lehmann S et al. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2000: 25: 993.
33. Nattakom TV, Charlton A, Wilmore DW. Use of vitamin E and glutamine in the successful treatment of severe veno-occlusive disease following bone marrow transplantation. Nutr Clin Pract 1995: 10: 16.
34. Kajiume T, Yoshimi S, Nagita A, Kobayashi K, Kataoka N. Application of nitric oxide for a case of veno-occlusive disease after peripheral blood stem cell transplantation. Pediatr Hematol Oncol 2000: 17: 601.
35. Khoury H, Adkins D, Brown R. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant 2000: 25: 737.
36. Richardson PG, Murakami C, Jin Z. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002: 100: 4337.
37. Richardson PG, Eliao AD, Krishnan A. Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population. Blood 1998: 92: 737.
38. Senzolo M, Cholongitao E, Patch D, Burroughs AK. TIPS for veno-occlusive disease: Is the contraindication real? Hepatology 2005: 42: 240.
39. Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant 2000: 25: 987.
40. Fried MW, Connaghan DG, Sharma S. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996: 24: 588.
41. Zenz T, Rossle M, Bertz H, Siegerstetter V, Ochs A, Finke J. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation - role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001: 21: 31.
42. Levy V, Azoulay D, Rio B et al. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS). Bone Marrow Transplant 1996: 18: 443.
43. Smith FO, Johnson MS, Scherer LR et al. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease. Bone Marrow Transplant 1996: 18: 643.
44. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases Practice Guidelines: The role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 2005: 16: 615.